JPMorgan Chase & Co’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.8M | Sell |
428,303
-353,891
| -45% | -$6.44M | ﹤0.01% | 2387 |
|
2025
Q1 | $15.5M | Buy |
782,194
+14,929
| +2% | +$296K | ﹤0.01% | 1863 |
|
2024
Q4 | $13.2M | Buy |
767,265
+561,310
| +273% | +$9.63M | ﹤0.01% | 2037 |
|
2024
Q3 | $4.12M | Sell |
205,955
-33,633
| -14% | -$672K | ﹤0.01% | 2751 |
|
2024
Q2 | $2.68M | Buy |
239,588
+32,707
| +16% | +$366K | ﹤0.01% | 2905 |
|
2024
Q1 | $1.37M | Buy |
206,881
+20,513
| +11% | +$135K | ﹤0.01% | 3379 |
|
2023
Q4 | $842K | Sell |
186,368
-964
| -0.5% | -$4.36K | ﹤0.01% | 3630 |
|
2023
Q3 | $671K | Buy |
187,332
+11,898
| +7% | +$42.6K | ﹤0.01% | 3595 |
|
2023
Q2 | $647K | Buy |
175,434
+1,210
| +0.7% | +$4.47K | ﹤0.01% | 3649 |
|
2023
Q1 | $577K | Sell |
174,224
-110,684
| -39% | -$367K | ﹤0.01% | 3746 |
|
2022
Q4 | $1.11M | Buy |
284,908
+174,912
| +159% | +$678K | ﹤0.01% | 3294 |
|
2022
Q3 | $268K | Buy |
109,996
+1,902
| +2% | +$4.63K | ﹤0.01% | 4041 |
|
2022
Q2 | $214K | Buy |
108,094
+28,988
| +37% | +$57.4K | ﹤0.01% | 4293 |
|
2022
Q1 | $144K | Buy |
79,106
+61,909
| +360% | +$113K | ﹤0.01% | 4599 |
|
2021
Q4 | $24K | Buy |
+17,197
| New | +$24K | ﹤0.01% | 5282 |
|
2021
Q3 | – | Sell |
-84,099
| Closed | -$135K | – | 5496 |
|
2021
Q2 | $135K | Buy |
84,099
+33,643
| +67% | +$54K | ﹤0.01% | 4665 |
|
2021
Q1 | $88K | Buy |
50,456
+6,899
| +16% | +$12K | ﹤0.01% | 4676 |
|
2020
Q4 | $85K | Buy |
43,557
+21,120
| +94% | +$41.2K | ﹤0.01% | 4343 |
|
2020
Q3 | $49K | Buy |
22,437
+2,186
| +11% | +$4.77K | ﹤0.01% | 4281 |
|
2020
Q2 | $59K | Sell |
20,251
-2,385
| -11% | -$6.95K | ﹤0.01% | 4166 |
|
2020
Q1 | $65K | Buy |
22,636
+6,136
| +37% | +$17.6K | ﹤0.01% | 4064 |
|
2019
Q4 | $66K | Sell |
16,500
-148,029
| -90% | -$592K | ﹤0.01% | 4150 |
|
2019
Q3 | $732K | Buy |
164,529
+157,020
| +2,091% | +$699K | ﹤0.01% | 3204 |
|
2019
Q2 | $28K | Buy |
7,509
+1,259
| +20% | +$4.7K | ﹤0.01% | 4449 |
|
2019
Q1 | $24K | Sell |
6,250
-23,654
| -79% | -$90.8K | ﹤0.01% | 4453 |
|
2018
Q4 | $72K | Sell |
29,904
-199,095
| -87% | -$479K | ﹤0.01% | 4156 |
|
2018
Q3 | $1.42M | Buy |
228,999
+81,003
| +55% | +$503K | ﹤0.01% | 2974 |
|
2018
Q2 | $667K | Buy |
147,996
+108,505
| +275% | +$489K | ﹤0.01% | 3320 |
|
2018
Q1 | $182K | Buy |
+39,491
| New | +$182K | ﹤0.01% | 3750 |
|